Stocks and Investing
Stocks and Investing
Mon, November 7, 2016
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 12:45 AM ] - United States, WOPRAI
[ 12:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sumant Kulkarni Downgraded (TEVA) to Hold on, Nov 7th, 2016
Sumant Kulkarni of B of A Securities, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold on, Nov 7th, 2016.
Sumant has made no other calls on TEVA in the last 4 months.
There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, 1 agrees with Sumant's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016
These are the ratings of the 4 analyists that currently disagree with Sumant
- Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016
- Derek Archila of "Oppenheimer" Upgraded from Hold to Buy on, Friday, September 2nd, 2016
- Ami Fadia of "Leerink Swann" Maintained at Buy with Decreased Target to $61 on, Wednesday, August 31st, 2016
- Tim Chiang of "BTIG" Maintained at Strong Buy and Held Target at $75 on, Wednesday, August 24th, 2016
Contributing Sources